Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relay Therapeutics (RLAY) Receivables - Other: 2020-2022

Historic Receivables - Other for Relay Therapeutics (RLAY) over the last 3 years, with Dec 2022 value amounting to $4.9 million.

  • Relay Therapeutics' Receivables - Other rose 5.21% to $4.9 million in Q1 2023 from the same period last year, while for Mar 2023 it was $4.9 million, marking a year-over-year increase of 5.21%. This contributed to the annual value of $4.9 million for FY2022, which is 8.29% up from last year.
  • Per Relay Therapeutics' latest filing, its Receivables - Other stood at $4.9 million for FY2022, which was up 8.29% from $4.5 million recorded in FY2021.
  • Relay Therapeutics' Receivables - Other's 5-year high stood at $7.7 million during FY2020, with a 5-year trough of $4.5 million in FY2021.
  • Moreover, its 3-year median value for Receivables - Other was $4.9 million (2022), whereas its average is $5.7 million.
  • Per our database at Business Quant, Relay Therapeutics' Receivables - Other tumbled by 40.72% in 2021 and then climbed by 8.29% in 2022.
  • Over the past 3 years, Relay Therapeutics' Receivables - Other (Yearly) stood at $7.7 million in 2020, then plummeted by 40.72% to $4.5 million in 2021, then grew by 8.29% to $4.9 million in 2022.